Advertisement

Topics

Alimera sees second quarter revenue increase

08:30 EDT 7 Aug 2017 | Healio

Alimera Sciences had an increase in consolidated net revenue of 8% to $10.4 million in the second quarter of 2017 compared with $9.6 million in the second quarter of 2016. U.S. revenue increased from $7.2 million to $8.1 million, driven by higher sales of Iluvien (fluocinolone acetonide intravitreal implant 0.19 mg), while international revenue remained flat at $2.3 million, according to a company press release.

Original Article: Alimera sees second quarter revenue increase

NEXT ARTICLE

More From BioPortfolio on "Alimera sees second quarter revenue increase"

Quick Search
Advertisement
 

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...